• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

American Gastroenterological Association technical review on the management of hepatitis C.

作者信息

Dienstag Jules L, McHutchison John G

机构信息

Gastrointestinal Unit (Medical Services) Massachusetts General Hospital, Department of Medicine and Office of the Dean for Medical Education, Harvard Medical School, Boston, Massachusetts, USA.

出版信息

Gastroenterology. 2006 Jan;130(1):231-64; quiz 214-7. doi: 10.1053/j.gastro.2005.11.010.

DOI:10.1053/j.gastro.2005.11.010
PMID:16401486
Abstract
摘要

相似文献

1
American Gastroenterological Association technical review on the management of hepatitis C.美国胃肠病学会关于丙型肝炎管理的技术审查
Gastroenterology. 2006 Jan;130(1):231-64; quiz 214-7. doi: 10.1053/j.gastro.2005.11.010.
2
American Gastroenterological Association medical position statement on the management of hepatitis C.美国胃肠病学会关于丙型肝炎管理的医学立场声明。
Gastroenterology. 2006 Jan;130(1):225-30. doi: 10.1053/j.gastro.2005.11.011.
3
[Chronic hepatitis C with repeatedly normal transaminase levels].转氨酶水平反复正常的慢性丙型肝炎
Rom J Gastroenterol. 2002 Jun;11(2):129-33.
4
Treatment of chronic Hepatitis C: a smart coat over a ragged dress?慢性丙型肝炎的治疗：破旧衣衫外的华丽外衣？
Dig Liver Dis. 2009 Jul;41(7):465-6. doi: 10.1016/j.dld.2009.04.001. Epub 2009 May 1.
5
Diagnosis, management, and treatment of hepatitis C.丙型肝炎的诊断、管理与治疗。
Hepatology. 2004 Apr;39(4):1147-71. doi: 10.1002/hep.20119.
6
Alcohol and hepatitis C: do we have a drinking problem?
Gastroenterology. 2006 May;130(6):1912-4. doi: 10.1053/j.gastro.2006.03.030.
7
Hepatitis C and renal transplantation: a review on historical aspects and current issues.丙型肝炎与肾移植：历史回顾与当前问题
Rev Med Virol. 2008 Nov-Dec;18(6):375-86. doi: 10.1002/rmv.590.
8
Is {beta}-interferon a promising therapeutic option for the management of hepatitis C?
J Antimicrob Chemother. 2009 Jun;63(6):1097-103. doi: 10.1093/jac/dkp092. Epub 2009 Mar 27.
9
[Chronic hepatitis C in children: natural history and prognosis].[儿童慢性丙型肝炎：自然史与预后]
Recenti Prog Med. 2009 Feb;100(2):97-102.
10
Expanded hepatitis C virus screening recommendations promote opportunities for care and cure.扩大丙型肝炎病毒筛查建议为治疗和治愈创造了机会。
Ann Intern Med. 2013 Sep 3;159(5):364-5. doi: 10.7326/0003-4819-159-5-201309030-00675.

引用本文的文献

1
Risk factors and adverse outcomes associated with hepatitis C virus in pregnancy.妊娠期间丙型肝炎病毒相关的危险因素及不良结局。
J Perinat Med. 2025 May 28. doi: 10.1515/jpm-2025-0146.
2
Cascade of immune mechanism and consequences of inflammatory disorders.级联免疫机制和炎症性疾病的后果。
Phytomedicine. 2021 Oct;91:153712. doi: 10.1016/j.phymed.2021.153712. Epub 2021 Aug 19.
3
The Frequency and Risk Factors Identified for HBsAg and Anti-HCV in a Preoperative Screening of Patients Admitted in the Surgical Department at Al-Tibri Medical College Hospital.
在阿尔-提卜医学院医院外科收治患者的术前筛查中确定的乙肝表面抗原（HBsAg）和抗丙型肝炎病毒（Anti-HCV）的频率及危险因素
Cureus. 2020 Jul 1;12(7):e8938. doi: 10.7759/cureus.8938.
4
Lectins from red algae and their biomedical potential.红藻凝集素及其生物医学潜力。
J Appl Phycol. 2018;30(3):1833-1858. doi: 10.1007/s10811-017-1338-5. Epub 2017 Nov 20.
5
New direct-acting antivirals for hepatitis C treatment and neuropsychiatric symptoms in psychiatric risk groups.用于丙型肝炎治疗的新型直接抗病毒药物与精神疾病风险群体中的神经精神症状
Eur J Hosp Pharm. 2019 May;26(3):135-139. doi: 10.1136/ejhpharm-2017-001352. Epub 2018 Jan 27.
6
Efficacy and Safety of Avatrombopag in Patients With Thrombocytopenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.阿伐曲泊帕治疗血小板减少症患者的疗效和安全性：一项随机对照试验的系统评价和荟萃分析
Front Pharmacol. 2019 Jul 26;10:829. doi: 10.3389/fphar.2019.00829. eCollection 2019.
7
Risk of rheumatoid arthritis in patients with hepatitis C virus infection receiving interferon-based therapy: a retrospective cohort study using the Taiwanese national claims database.接受基于干扰素治疗的丙型肝炎病毒感染患者患类风湿性关节炎的风险：一项使用台湾全民健康保险研究数据库的回顾性队列研究
BMJ Open. 2018 Jul 23;8(7):e021747. doi: 10.1136/bmjopen-2018-021747.
8
Tackling HCV-3 in Asia: Breakthroughs for Efficient and Cost-effective Treatment Strategies.应对亚洲的丙型肝炎病毒-3型：高效且具成本效益的治疗策略的突破
Euroasian J Hepatogastroenterol. 2016 Jan-Jun;6(1):35-42. doi: 10.5005/jp-journals-10018-1163. Epub 2016 Jul 9.
9
Rapid reversal of innate immune dysregulation in blood of patients and livers of humanized mice with HCV following DAA therapy.在接受直接抗病毒药物（DAA）治疗后，丙型肝炎病毒（HCV）感染患者血液和人源化小鼠肝脏中固有免疫失调的快速逆转。
PLoS One. 2017 Oct 17;12(10):e0186213. doi: 10.1371/journal.pone.0186213. eCollection 2017.
10
Efficient Hepatitis C Virus Genotype 1b Core-NS5A Recombinants Permit Efficacy Testing of Protease and NS5A Inhibitors.高效丙型肝炎病毒1b基因型核心-NS5A重组体可用于蛋白酶和NS5A抑制剂的疗效测试。
Antimicrob Agents Chemother. 2017 May 24;61(6). doi: 10.1128/AAC.00037-17. Print 2017 Jun.